tirzepatide compound illegal First raid on UK weight loss drug factory in Northampton Compounded Tirzepatide Alternatives Vanish as

Melanotropic peptides: more than just 'Barbie drugs' and 'sun-tan jabs'

Fifteen percent of Americans are now on a GLP-1 drug, according to Circana, and Morgan Stanley predicts 55 million Americans will be on one by 2035

Apabetalone and hospitalization for heart failure in patients following an acute coronary syndrome: a prespecified analysis of the BETonMACE study

Patients receiving GLP-1 agonists showed meaningful improvements in Binge Eating Scale scores

Larger, long-term studies are needed to confirm their effectiveness, especially in patients without metabolic conditions, to clarify their role in psoriasis treatment